Literature DB >> 22421964

dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8.

Y Estornes1, F Toscano, F Virard, G Jacquemin, A Pierrot, B Vanbervliet, M Bonnin, N Lalaoui, P Mercier-Gouy, Y Pachéco, B Salaun, T Renno, O Micheau, S Lebecque.   

Abstract

Toll-like receptor 3 (TLR3) is a pattern-recognition receptor known to initiate an innate immune response when stimulated by double-stranded RNA (dsRNA). Components of TLR3 signaling, including TIR domain-containing adapter inducing IFN-α (TRIF), have been demonstrated to contribute to dsRNA-induced cell death through caspase-8 and receptor interacting protein (RIP)1 in various human cancer cells. We provide here a detailed analysis of the caspase-8 activating machinery triggered in response to Poly(I:C) dsRNA. Engagement of TLR3 by dsRNA in both type I and type II lung cancer cells induces the formation of an atypical caspase-8-containing complex that is devoid of classical death receptors of the TNFR superfamily, but instead is physically associated to TLR3. The recruitment of caspase-8 to TLR3 requires RIP1, and is negatively modulated by cellular inhibitor of apoptosis protein (cIAP)2-TNF receptor-associated factor (TRAF)2-TNFR-associated death domain (TRADD) ubiquitin ligase complex, which regulates RIP1 ubiquitination. Intriguingly, unlike Fas- or TRAILR-dependent death signaling, caspase-8 recruitment and activation within the TLR3 death-signaling complex appears not to be stringently dependent on Fas-associated with death domain (FADD). Our findings uncover a novel aspect of the molecular mechanisms involved during apoptosis induced by the innate immune receptor TLR3 in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421964      PMCID: PMC3422471          DOI: 10.1038/cdd.2012.22

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer.

Authors:  Bruno Salaun; Laurence Zitvogel; Carine Asselin-Paturel; Yannis Morel; Karine Chemin; Clarisse Dubois; Catherine Massacrier; Rosa Conforti; Marie Pierre Chenard; Jean-Christophe Sabourin; Aicha Goubar; Serge Lebecque; Michel Pierres; Donata Rimoldi; Pedro Romero; Fabrice Andre
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

2.  DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells.

Authors:  Zhiqiang Zhang; Taeil Kim; Musheng Bao; Valeria Facchinetti; Sung Yun Jung; Amir Ali Ghaffari; Jun Qin; Genhong Cheng; Yong-Jun Liu
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

3.  RIP1 comes back to life as a cell death regulator in TNFR1 signaling.

Authors:  Marie Anne O'Donnell; Adrian T Ting
Journal:  FEBS J       Date:  2011-02-08       Impact factor: 5.542

4.  The ribonucleotide reductase R1 subunits of herpes simplex virus 1 and 2 protect cells against poly(I · C)-induced apoptosis.

Authors:  Florent Dufour; Luc Bertrand; Angela Pearson; Nathalie Grandvaux; Yves Langelier
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

Review 5.  Innate immunity to virus infection.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

6.  Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.

Authors:  Miwa Sasai; Megumi Tatematsu; Hiroyuki Oshiumi; Kenji Funami; Misako Matsumoto; Shigetsugu Hatakeyama; Tsukasa Seya
Journal:  Mol Immunol       Date:  2010-01-04       Impact factor: 4.407

7.  The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs.

Authors:  Tencho Tenev; Katiuscia Bianchi; Maurice Darding; Meike Broemer; Claudia Langlais; Fredrik Wallberg; Anna Zachariou; Juanita Lopez; Marion MacFarlane; Kelvin Cain; Pascal Meier
Journal:  Mol Cell       Date:  2011-07-07       Impact factor: 17.970

8.  The death domain kinase RIP1 links the immunoregulatory CD40 receptor to apoptotic signaling in carcinomas.

Authors:  Pauline G Knox; Clare C Davies; Marina Ioannou; Aristides G Eliopoulos
Journal:  J Cell Biol       Date:  2011-01-31       Impact factor: 10.539

9.  cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms.

Authors:  Maria Feoktistova; Peter Geserick; Beate Kellert; Diana Panayotova Dimitrova; Claudia Langlais; Mike Hupe; Kelvin Cain; Marion MacFarlane; Georg Häcker; Martin Leverkus
Journal:  Mol Cell       Date:  2011-07-07       Impact factor: 17.970

10.  Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.

Authors:  Sarah E Ewald; Alex Engel; Jiyoun Lee; Miqi Wang; Matthew Bogyo; Gregory M Barton
Journal:  J Exp Med       Date:  2011-03-14       Impact factor: 14.307

View more
  63 in total

1.  TAX1BP1 Restrains Virus-Induced Apoptosis by Facilitating Itch-Mediated Degradation of the Mitochondrial Adaptor MAVS.

Authors:  Young Bong Choi; Noula Shembade; Kislay Parvatiyar; Siddharth Balachandran; Edward William Harhaj
Journal:  Mol Cell Biol       Date:  2016-12-19       Impact factor: 4.272

2.  Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.

Authors:  William J Kaiser; Haripriya Sridharan; Chunzi Huang; Pratyusha Mandal; Jason W Upton; Peter J Gough; Clark A Sehon; Robert W Marquis; John Bertin; Edward S Mocarski
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 3.  RIP kinases: key decision makers in cell death and innate immunity.

Authors:  F Humphries; S Yang; B Wang; P N Moynagh
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

4.  Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b+Ly6G+ intratumor myeloid cells through the TICAM-1 signaling pathway.

Authors:  Hiroaki Shime; Misako Matsumoto; Tsukasa Seya
Journal:  Cell Death Differ       Date:  2016-11-11       Impact factor: 15.828

5.  IL-24 sensitizes tumor cells to TLR3-mediated apoptosis.

Authors:  R Weiss; M Sachet; J Zinngrebe; T Aschacher; M Krainer; B Hegedus; H Walczak; M Bergmann
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

Review 6.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

7.  TLR3, TRIF, and caspase 8 determine double-stranded RNA-induced epithelial cell death and survival in vivo.

Authors:  Christopher S McAllister; Omar Lakhdari; Guillaume Pineton de Chambrun; Mélanie G Gareau; Alexis Broquet; Gin Hyug Lee; Steven Shenouda; Lars Eckmann; Martin F Kagnoff
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

8.  CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN.

Authors:  Diana Legarda; Scott J Justus; Rosalind L Ang; Nimisha Rikhi; Wenjing Li; Thomas M Moran; Jianke Zhang; Emiko Mizoguchi; Matija Zelic; Michelle A Kelliher; J Magarian Blander; Adrian T Ting
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

Review 9.  The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling.

Authors:  Peter Vandenabeele; Mathieu J M Bertrand
Journal:  Nat Rev Immunol       Date:  2012-11-05       Impact factor: 53.106

10.  Differential effects of phenethyl isothiocyanate and D,L-sulforaphane on TLR3 signaling.

Authors:  Jianzhong Zhu; Arundhati Ghosh; Elizabeth M Coyle; Joomin Lee; Eun-Ryeong Hahm; Shivendra V Singh; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.